For help on how to get the results you want, see our search tips.
2 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral type
Article 29(4) referrals Remove Article 29(4) referrals filter
Article 20 procedures Remove Article 20 procedures filter
Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter
Article 13 referrals Remove Article 13 referrals filter
Article 35 Remove Article 35 filter
Article 30 referrals Remove Article 30 referrals filter
Referral authorisation model
Nationally authorised product(s) Remove Nationally authorised product(s) filter
-
List item
Referral: Lidocain/Prilocain Idetec and associated names
lidocaine, prilocaine, associated names: Lidocaïne / Prilocaïne 5% Focus, Crème, Article 29(4) referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 14/10/2021, Last updated: 21/04/2022 -
List item
Referral: Daruph and Anafezyn (new)
dasatinib (anhydrous), associated names: Dasatinib Zentiva, Article 29(4) referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 19/05/2022, Last updated: 20/05/2022